相关实验视频

Updated: Jan 10, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

在使用CRISPR/Cas9系统的人类纤维瘤细胞中的原蛋白1α型基因突变

SoHyun Park¹, Moon-Moo Kim²

¹Graduate School of Department of Applied Chemistry and Food Science Technology, Dong-Eui University, Busan 47340, Republic of Korea.

|November 24, 2025

概括

编辑原蛋白1型α (COL1A1) 基因减少了原蛋白的产生,并增加了细胞衰老. 这项研究揭示了COL1A1基因编辑,原水平和衰老之间的联系.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
遗传学是一个遗传学.

背景情况:

原蛋白对连接组织和衰老表型至关重要.
衰老涉及降低原蛋白的生产和增加原蛋白分解.
原信号通路在衰老中的作用需要进一步研究.

研究的目的:

为了研究原信号传递,细胞周期和衰老表型的变化.
在CRISPR/Cas9编辑 COL1A1 基因后分析基因和蛋白质表达.
了解COL1A1基因突变对细胞衰老的影响.

主要方法:

编辑CRISPR/Cas9基因以诱导纤维瘤细胞中的COL1A1突变.
桑格DNA测序和瑞士蛋白质建模用于突变验证.
检测包括原染色,SA-β-银酸酶,RT-PCR,西斑,发泡镜和免疫光检测,以评估衰老的表型.

主要成果:

成功建立了具有改变蛋白质结构的COL1A1突变细胞.
在编辑的细胞中减少了原蛋白的产生和增加了SA-β-galactosidase染色 (衰老标记物).
对CDC2,CDk2,cyclin D和MDM2的上调,对p53,p21,MMP-1,MMP-2,MMP-9,AKT和p-mTOR进行下调.

结论:

COL1A1基因编辑影响原蛋白的产生,并诱导细胞衰老.
细胞循环调节剂 (p53,p21,MDM2) 和原酶 (MMPs) 的改变表达与衰老有关.
研究结果表明,原体代谢与衰老过程之间存在重要联系.

更多相关视频

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...